2024年10月31日 · Combivent Respimat is used to prevent bronchospasm in people with chronic obstructive pulmonary disease (COPD). Includes Combivent side effects, interactions and indications.

COMBIVENT RESPIMAT (ipratropium bromide and albuterol) is indicated for use in patients with chronic obstructive pulmonary disease (COPD) on a regular aerosol bronchodilator who continue to have evidence of bronchospasm (airway narrowing) and who require a second bronchodilator.

COMBIVENT RESPIMAT may increase eye pressure which may cause or worsen some types of glaucoma. If you have sudden vision changes, eye pain or visual halos, stop taking COMBIVENT RESPIMAT and call your doctor right away. COMBIVENT RESPIMAT may cause difficulty with urination. Dizziness and blurred vision may occur with COMBIVENT RESPIMAT.

2024年3月25日 · Combivent package insert / prescribing information for healthcare professionals. Includes: indications, dosage, adverse reactions and pharmacology.

COMBIVENT RESPIMAT (ipratropium bromide and albuterol) is indicated for use in patients with chronic obstructive pulmonary disease (COPD) on a regular aerosol bronchodilator who continue to have evidence of bronchospasm (airway narrowing) and who require a second bronchodilator.

2024年9月25日 · Combivent Respimat are bronchodilators that relax muscles in the airways and increase air flow to the lungs. Combivent Respimat is used to prevent bronchospasm in people with chronic obstructive pulmonary disease (COPD) who are also using other medicines to …

COMBIVENT RESPIMAT is a combination of ipratropium bromide (an anticholinergic agent) and albuterol sulfate (a beta2-adrenergic agonist) indicated for use in patients with chronic obstructive ... The recommended dose of COMBIVENT RESPIMAT is one inhalation four times a day.

COMBIVENT RESPIMAT is contraindicated in patients hypersensitive to any of the ingredients of the drug product or to atropine or its derivatives. COMBIVENT RESPIMAT can produce paradoxical bronchospasm that can be life-threatening. If it occurs, therapy with COMBIVENT RESPIMAT should be discontinued immediately and alternative therapy instituted.

Discover Combivent Respimat a anticholinergic & beta-adrenergic for patients requiring more than one bronchodilator, to manage reversible bronchospasms.

COMBIVENT RESPIMAT is indicated for use in patients with chronic obstructive pulmonary disease (COPD) on a regular aerosol bronchodilator who continue to have evidence of bronchospasm and who require a second bronchodilator.